4D pharma plc Comprehensive Income
4D pharma plc reported Comprehensive Income of -$32.11 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-03-31
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|
| 2021-12-31 | -$32.11M 20-F · filed 2022-03-31 | ||
| 2021-06-30 | -$24.25M 6-K/A · filed 2022-02-18 | -$18.48M 6-K · filed 2021-10-01 | |
| 2020-12-31 | -$28.93M 20-F · filed 2022-03-31 | ||
| 2020-06-30 | -$16.85M 6-K/A · filed 2022-02-18 | ||
| 2019-12-31 | -$29.22M 20-F · filed 2022-03-31 | ||
| 2018-12-31 | -$36.60M 20-F/A · filed 2021-04-30 |